<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 17 Nov 2026 18:23:30 -0500--><rss version="2.0">
    <channel>
        <title>Corbus Pharmaceuticals Holdings, Inc. (CRBP) SEC Filings</title>
        <link>https://ir.corbuspharma.com/sec-filings/all-sec-filings/rss</link>
        <description>Corbus Pharmaceuticals Holdings, Inc. (CRBP) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_dc5231ac157b9ee4fb322b64fcb7a082/corbuspharma/files/theme/images/logo-sm.png</url>
                <title>Corbus Pharmaceuticals Holdings, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[3 Related Documents: 8-K, EX-99.1, EX-99.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-462186/0001193125-26-462186.pdf</link>
                <pubDate>Mon, 16 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-462186/0001193125-26-462186.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001687078-26-000022/0001687078-26-000022.pdf</link>
                <pubDate>Fri, 13 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001687078-26-000022/0001687078-26-000022.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-455614/0001193125-26-455614.pdf</link>
                <pubDate>Tue, 10 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-455614/0001193125-26-455614.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-454476/0001193125-26-454476.pdf</link>
                <pubDate>Tue, 10 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-454476/0001193125-26-454476.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000929638-26-004182/0000929638-26-004182.pdf</link>
                <pubDate>Mon, 02 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000929638-26-004182/0000929638-26-004182.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000929638-26-004181/0000929638-26-004181.pdf</link>
                <pubDate>Mon, 02 Nov 26 00:00:00 -0500</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0000929638-26-004181/0000929638-26-004181.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001716774-26-000025/0001716774-26-000025.pdf</link>
                <pubDate>Thu, 29 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001716774-26-000025/0001716774-26-000025.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-422437/0001193125-26-422437.pdf</link>
                <pubDate>Thu, 15 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-422437/0001193125-26-422437.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G, EX-99.1]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001346824-26-000243/0001346824-26-000243.pdf</link>
                <pubDate>Wed, 30 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001346824-26-000243/0001346824-26-000243.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-392093/0001193125-26-392093.pdf</link>
                <pubDate>Tue, 15 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-392093/0001193125-26-392093.pdf</guid>
                                                                            </item>
            </channel>
</rss>